[1]
N. Mahadkar, D. S. Dhoot, and H. Barkate, “Comparative real-world effectiveness and safety of super-bioavailable itraconazole 50 mg bd and 65 mg bd in the management of dermatophytosis”, Int J Res Dermatol, vol. 8, no. 4, pp. 433–436, Jun. 2022.